Massachusetts Moves Forward In Decriminalizing Psychedelics
Marijuana Stocks, Finance, & InvestingUncategorized February 25, 2021
Massachusetts lawmakers are moving forward to decriminalize psychedelic drugs. T
Read morePsychedelic Drug Stocks Then-And-Now: Six Months Ago Versus Today
Marijuana Stocks, Finance, & InvestingUncategorized February 25, 2021
Psychedelic stocks are well off of their 2020 highs. But they are even further from their 2020 lows. Opportunity knocks.
Read moreNew Jersey Gov. Signs Bill to Legalize Cannabis
Marijuana Stocks, Finance, & InvestingUncategorized February 23, 2021
After over three months since voters approved the state’s cannabis legalization ballot question, New Jersey Gov. Phil Murphy (D) today signed into law a series of bills that ultimately legalize the adult use of cannabis.
Read moreWhy Is Everyone So Obsessed With Mushrooms Right Now?
Marijuana Stocks, Finance, & InvestingUncategorized February 23, 2021
It used to be that the only time I really saw mushrooms was when a few white button mushrooms appeared on a garden salad or atop my cheese pizza.
Read moreProposed California Psychedelics Bill Would Be Sector Turning Point
Marijuana Stocks, Finance, & InvestingUncategorized February 22, 2021
California’s new proposed psychedelics “decriminalization” would, in fact, LEGALIZE possession of many psychedelic substances.
Read moreMINDCURE’s Proprietary Bioinformatics Platform, PsyCollage, Beta Tested and Deployed for Product Discovery and Lead Optimization
Marijuana Stocks, Finance, & InvestingUncategorized February 19, 2021
MINDCURE adds bioinformatics to its drug development platform.
Read moreMind Cure Engages Dr. Dan Engle as Primary Investigator for Research in Traumatic Brain Injury with Psychedelics
Marijuana Stocks, Finance, & InvestingUncategorized February 19, 2021
Dr. Dan Engle, a noted expert in neurology, will lead MINDCURE’s psychedelic drug research on traumatic brain injury
Read moreMINDCURE’s Psychedelics R&D Targets Blockbuster TBI Treatment Market
Marijuana Stocks, Finance, & InvestingUncategorized February 19, 2021
MINDCURE’s R&D on traumatic brain injury (TBI) targets the LARGEST individual market for psychedelic drugs.
Read moreCan LSD cure our pandemic anxiety? MindMed is spending big to find out
Marijuana Stocks, Finance, & InvestingUncategorized February 19, 2021
While many people will look back on the pandemic as a dark time, it has also spurred some positive developments—most notably in the field of drug development, where miraculous breakthroughs like mRNA vaccines are transforming immunology.
Read moreMindset Pharma Added to North American Psychedelics Index
Marijuana Stocks, Finance, & InvestingUncategorized February 19, 2021
Toronto, Ontario– Mindset Pharma Inc., a drug discovery and development company focused on developing next generation psilocybin-inspired medicines and related technologies, is pleased to announce that effective today, it has been added to the North American Psychedelics Index which is provided by German-based index provider, Solactive.
Read more